References
- Baglai A., Blokland M.H., Mol H.G.J., Gargano A.F.G., Van der Wal S., Schoenmakers P.J.: Enhancing detectability of anabolic-steroid residues in bovine urine by actively modulated online comprehensive two-dimensional liquid chromatography – high resolution mass spectrometry. Anal Chim Acta 2018, 1013, 87–97, doi: 10.1016/j.aca.2017.12.043.
- Council of the European Union: Council Directive 96/22/EC of 29 April 1996, concerning the prohibition on the use in stockfarming of certain substances having a hormonal or thyreostatic action and of β-agonists, and repealing Directives 81/602/EEC, 88/146/EEC and 88/299/EEC. OJEC L 1996, 125, 39, 23/05/1996, 3–9, http://data.europa.eu/eli/dir/1996/22/oj.
- Crabbe P., Meyer U.J., Zhi Z.L., Pieraccini G., O’Keeffe M., Van Peteghem C.: Screening of Clostebol and its metabolites in Bovine Urine with ELISA and Comparison with GC-MS Results in an Interlaboratory Study. J Anal Toxicol 2003, 27, 213–220, https://academic.oup.com/jat/article/27/4/213/721348.
- Crabbe P., Pieraccini G., Bartolucci G., Moneti G., Van Peteghem C.: Influence of Helix pomatia Enzyme Preparations on the Oxidative Conversion of Some Clostebol Acetate metabolites in Urine. J Anal Toxicol 2002, 26, 73–80, https://academic.oup.com/jat/article/26/2/73/739248.
- Crabbe P., Van Peteghem C., Salden M., Kohen F.: Influence of the hapten conjugation site on the characteristics of antibodies generated against metabolites of clostebol acetate. J Agric Food Chem 2000, 48, 3633–3638, doi: 10.1021/jf9906984.
- De la Torre X., Colamonici C., Iannone M., Jardines D., Molaioni F., Botre F.: Detection of clostebol in sports: Accidental doping? Drug Test Anal 2020, 12, 1561–1569, doi: 10.1002/dta.2951.
- Directorate-General for Health and Food Safety of the European Commission, European Union Reference Laboratories: EURL Guidance on Minimum Method Performance Requirements (MMPRs) for specific pharmacologically active substances in specific animal matrices, Version 2.0 June 2022. Directorate-General for Health and Food Safety, Brussels, 2022, https://eurl-residues.eu/wp-content/uploads/2022/06/EURL_MMPR_guidance_endorsed.pdf.
- European Commission: Commission Delegated Regulation (EU) 2022/1644 of 7 July 2022 supplementing Regulation (EU) 2017/625 of the European Parliament and of the Council with specific requirements for the performance of official controls on the use of pharmacologically active substances authorised as veterinary medicinal products or as feed additives and of prohibited or unauthorized pharmacologically active substances and residues thereof. OJEU L 2022, 248, 65,26/09/2022, 3–17, https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX: 32022R1644.
- European Commission: Commission Implementing Regulation (EU) 2021/808 of 22 March 2021 on the performance of analytical methods for residues of pharmacologically active substances used in food-producing animals and on the interpretation of results as well as on the methods to be used for sampling and repealing Decisions 2002/657/EC and 98/179/EC. OJEU L 2021, 180, 64, 26/03/2021, 84–109, http://data.europa.eu/eli/reg_impl/2021/808/oj.
- European Commission: Commission Implementing Regulation (EU) 2022/1646 of 23 September 2022 on uniform practical arrangements for the performance of official controls as regards the use of pharmacologically active substances authorised as veterinary medicinal products or as feed additives and of prohibited or unauthorised pharmacologically active substances and residues thereof, on specific content of multi-annual national control plans and specific arrangements for their preparation. OJEU L 2022, 248, 65, 26/09/2022, 32–45, https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32022R1646.
- European Food Safety Authority: Report for 2022 on the results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products. EFSA Supporting Publications 2024, 101, EN-8669, doi: 10.2903/sp.efsa. 2024.EN-8669.
- European Parliament and the Council of the European Union: Directive 2003/74/EC of 22 September 2003 amending Council Directive 96/22/EC concerning the prohibition on the use in stockfarming of certain substances having hormonal or thyreostatic action and of beta agonists. OJEC L 2003, 262, 46, 14/10/2003, 17–0021, https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32003L0074&from=en.
- European Parliament and the Council of the European Union: Directive 2008/97/EC of 19 November 2008 amending Council Directive 96/22/EC concerning the prohibition on the use in stockfarming of certain substances having a hormonal or thyreostatic action and of beta-agonists. OJEU L 2008, 318, 51, 28/11/2008, 9–11, https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32008L0097.
- European Parliament and the Council of the European Union: Regulation (EU) 2017/625 of the European Parliament and of the Council of 15 March 2017 on official controls and other official activities performed to ensure the application of food and feed law, rules on animal health and welfare, plant health and plant protection products, amending Regulations (EC) No 999/2001, (EC) No 396/2005, (EC) No 1069/2009, (EC) No 1107/2009, (EU) No 1151/2012, (EU) No 652/2014, (EU) 2016/429 and (EU) 2016/2031 of the European Parliament and of the Council, Council Regulations (EC) No 1/2005 and (EC) No 1099/2009 and Council Directives 98/58/EC, 1999/74/EC, 2007/43/EC, 2008/119/EC and 2008/120/EC, and repealing Regulations (EC) No 854/2004 and (EC) No 882/2004 of the European Parliament and of the Council, Council Directives 89/608/EEC, 89/662/EEC, 90/425/EEC, 91/496/EEC, 96/23/EC, 96/93/EC and 97/78/EC and Council Decision 92/438/EEC (Official Controls Regulation). OJEU L 2017, 95, 60, 07/04/2017, 1–142, http://data.europa.eu/eli/reg/2017/625/oj.
- Gessner L., Thevis M., Rothschild M.A., Jübner M.: Detectability of oxandrolone, metandienone, clostebol and dehydrochloromethyltestosterone in urine after transdermal application. Drug Test Anal 2022, 14, 1744–1761, doi: 10.1002/dta.3355.
- Guan F., Uboh C.E., Soma L.R., You Y., Liu Y., Li X.: High-throughput UHPLC-MS/MS method for the detection, quantification and identification of fifty-five anabolic and androgenic steroids in equine plasma. J Mass Spectrom 2010, 45, 1270–1279, doi: 10.1002/jms.1816.
- Hajrulaj-Musliu Z., Uzunov R., Jovanov S., Jankuloski D., Stojkovski V., Pendovski L., Sasanya J.J.: A new LC-MS/MS method for multiple residues/contaminants in bovine meat. BMC Chemistry 2022, 15, 62–82, doi: 10.1186/s13065-021-00788-5.
- Hamoir T., Courtheyn D., De Brabander H., Delahaut P., Leyssense L., Pottiea G.: Comparison of purification procedures for the isolation and detection of anabolic residues in faeces using gas chromatography-mass spectrometry. Analyst 1998, 12, 2621– 2624, https://hdb.ugent.be/HDB/Publications_A1_files/P1998-10%20%28Fe%29.pdf.
- Le Bizec B., Montrade M.P., Monteau F., Gaudin I., André F.: 4-Chlorotestosterone acetate metabolites in cattle after intramuscular and oral administrations. Clin Chem 1998, 44, 973– 984, https://academic.oup.com/clinchem/article/44/5/973/5642651.
- Le Bizec B., Van Hoof N., Courtheyn D., Gaudin I., Van De Wiele M., Bichon E., De Brabander H., André F.: New anabolic steroid illegally used in cattle-structure elucidation of 19-norchlorotestosterone acetate metabolites in bovine urine. J Steroid Biochem Mol Biol 2006, 98, 78–89, doi: 10.1016/j.jsbmb.2005.07.008.
- Leung G.N.W., Ho E.N.M., Leung D.K.K., Tang F.P.W., Wan T.S.M., Yeung J.H.K., Wang H.N.C.: Metabolic studies of clostebol acetate in horses. Chromatographia 2005, 61, 397–402, doi: 10.1365/s10337-005-0529-4.
- Leyssens L., Royackers E., Gielen B., Missotten M., Schoofs J., Czech J., Noben J.P., Hendriks L, Raus J.: Metabolites of 4-chlorotestosterone acetate in cattle urine as diagnostic markers for its illegal use. J Chromatogr B Biomed Sci Appl 1994, 654, 43–54, doi: 10.1016/0378-4347(94)00009-3.
- Lu J., Fernandez-Alvarez M., Yang S., He G., Xu Y., Aguilera R.: New clostebol metabolites in human urine by liquid chromatography time-of-flight tandem mass spectrometry and their application for doping control. J Mass Spectrom 2015, 50, 191–197, doi: 10.1002/jms.3517.
- Pereira H.M.G., Marques M.A.S., Talhas I.B., Radler Aquino Neto F.: Incidental Clostebol Contamination in Athletes after Sexual Intercourse. Clin Chem 2004, 50, 456–457, doi: 10.1373/clinchem.2003.022210.
- Protti M., Marasca C., Cirrincione M., Sberna M.E., Mandrioli R., Mercolini L.: Dried urine microsampling coupled to liquid chromatography-tandem mass spectrometry (LC-MS/MS) for the analysis of unconjugated anabolic androgenic steroids. Molecules 2020, 25, 3210–3227, doi: 10.3390/molecules25143210.
- Salomone A., Gerace E., Di Corcia D., Alladio E., Vincenti M., Kintz P.: Hair analysis can provide additional information in doping and forensic cases involving clostebol. Drug Test Anal 2019, 11, 95–101, doi: 10.1001/dta.2469.
- Schänzer W.: Metabolism of anabolic androgenic steroids. Clin Chem 1996, 42, 1001–1020, doi: 10.1093/CLINCHEM/42.7.1001.
- Skoupá K., Št’astný K., Sládek Z.: Anabolic Steroids in Fattening Food-Producing Animals – A Review, doi: 10.3390/ani12162115.
- Van Puymbroeck M., Kuilman M.E.M., Maas R.F.M., Witkamp R.F., Leyssens L., Vanderzande D., Gelan J., Raus J.: In vitro liver models are important tools to monitor the abuse of anabolic steroids in cattle. Analyst 1998, 123, 2453–2456, https://pubs.rsc.org/en/content/articlepdf/1998/an/a805013i.
- Venderink T., Sterk S.S.: Confidential WFSR Report 2022.525 (version 2). Proficiency test for A3 steroids in porcine and bovine urine. Wageningen Food Safety Research, Wageningen, the Netherlands, 2022.
- Walshe M., O’Keeffe M., Le Bizec B.: Studies on the determination of chlorotestosterone and its metabolites in bovine urine. Analyst 1998, 123, 2687–2691, doi: 10.1039/a805125i.
- World Anti-Doping Agency: 2021 Anti-Doping Testing Figures Report. World Anti-Doping Agency, Montreal, Canada, 2023, https://www.wada-ama.org/sites/default/files/2023-01/2021_anti-doping_testing_figures_en.pdf.
- World Anti-Doping Agency: World Anti-Doping Code International Standard Prohibited List. World Anti-Doping Agency, Montreal, Canada, 2023, https://www.wada-ama.org/sites/default/files/2023-09/2024list_en_final_22_september_2023.pdf.